Dr Brian Shimkus describes how he doses lenvatinib for renal cell carcinoma treatment.
2022 Genitourinary Cancers Symposium 2-Minute Drill: Experts Review Most Impactful Data
April 20th 2022Thought leaders Daniel P. Petrylak, MD; Benjamin H. Lowentritt, MD; Alan H. Bryce, MD; and Tanya Dorff, MD, joined CancerNetwork® following the 2022 Genitourinary Cancers Symposium to discuss highlights of the meeting in a game show–style production.